Ironwood Pharmaceuticals (NASDAQ:IRWD) Lowered to Buy at StockNews.com

StockNews.com lowered shares of Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Rating) from a strong-buy rating to a buy rating in a research report released on Monday. Separately, Piper Sandler upped their price target on Ironwood Pharmaceuticals from $16.00 to $19.00 in a research note on Tuesday, May 23rd. Ironwood Pharmaceuticals Price Performance Ironwood Pharmaceuticals stock opened […]

Related Keywords

Hillsdale ,Maryland ,United States ,Boston ,Massachusetts ,Piper Sandler ,Thomasa Mccourt ,Hillsdale Investment Management Inc ,Miller Howard Investments Inc ,Ironwood Pharmaceuticals Price Performance ,Mercer Global Advisors Inc ,Ironwood Pharmaceuticals Inc ,Institutional Trading Of Ironwood Pharmaceuticals ,News Ratings For Ironwood Pharmaceuticals Daily ,Ironwood Pharmaceuticals ,Pacer Advisors Inc ,Ironwood Pharmaceuticals Company Profile ,Securities Exchange Commission ,Get Rating ,Exchange Commission ,State Retirement ,Pension System ,Global Advisors ,Investment Management ,Howard Investments ,Pacer Advisors ,Human Therapeutics ,Ironwood Pharmaceuticals Daily ,